nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2E1—type 2 diabetes mellitus	0.132	0.387	CbGaD
Almotriptan—CYP1A2—type 2 diabetes mellitus	0.125	0.369	CbGaD
Almotriptan—CYP3A4—type 2 diabetes mellitus	0.0828	0.244	CbGaD
Almotriptan—HTR1D—Bromocriptine—type 2 diabetes mellitus	0.0413	0.0937	CbGbCtD
Almotriptan—HTR1B—Bromocriptine—type 2 diabetes mellitus	0.0396	0.0899	CbGbCtD
Almotriptan—CYP2C8—Sitagliptin—type 2 diabetes mellitus	0.0249	0.0565	CbGbCtD
Almotriptan—CYP2C8—Repaglinide—type 2 diabetes mellitus	0.0199	0.0452	CbGbCtD
Almotriptan—CYP2C8—Pioglitazone—type 2 diabetes mellitus	0.018	0.0409	CbGbCtD
Almotriptan—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0178	0.0403	CbGbCtD
Almotriptan—CYP2C8—Rosiglitazone—type 2 diabetes mellitus	0.0166	0.0377	CbGbCtD
Almotriptan—CYP2C8—Tolbutamide—type 2 diabetes mellitus	0.016	0.0364	CbGbCtD
Almotriptan—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0151	0.0343	CbGbCtD
Almotriptan—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0151	0.0343	CbGbCtD
Almotriptan—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0139	0.0316	CbGbCtD
Almotriptan—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0135	0.0306	CbGbCtD
Almotriptan—CYP2C8—Irbesartan—type 2 diabetes mellitus	0.0131	0.0297	CbGbCtD
Almotriptan—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0129	0.0292	CbGbCtD
Almotriptan—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0115	0.0261	CbGbCtD
Almotriptan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0113	0.0257	CbGbCtD
Almotriptan—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0106	0.0241	CbGbCtD
Almotriptan—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.0101	0.023	CbGbCtD
Almotriptan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0101	0.0229	CbGbCtD
Almotriptan—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00957	0.0217	CbGbCtD
Almotriptan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.00923	0.021	CbGbCtD
Almotriptan—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.0087	0.0198	CbGbCtD
Almotriptan—CYP2C8—Losartan—type 2 diabetes mellitus	0.00843	0.0191	CbGbCtD
Almotriptan—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00834	0.0189	CbGbCtD
Almotriptan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.00807	0.0183	CbGbCtD
Almotriptan—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00773	0.0175	CbGbCtD
Almotriptan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0073	0.0166	CbGbCtD
Almotriptan—CYP2C19—Losartan—type 2 diabetes mellitus	0.00707	0.0161	CbGbCtD
Almotriptan—CYP1A2—Losartan—type 2 diabetes mellitus	0.00652	0.0148	CbGbCtD
Almotriptan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00553	0.0126	CbGbCtD
Almotriptan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0053	0.012	CbGbCtD
Almotriptan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0053	0.012	CbGbCtD
Almotriptan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00502	0.0114	CbGbCtD
Almotriptan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00374	0.00848	CbGbCtD
Almotriptan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00342	0.00776	CbGbCtD
Almotriptan—Melatonin—MTNR1A—type 2 diabetes mellitus	0.00147	0.41	CrCbGaD
Almotriptan—Melatonin—MTNR1B—type 2 diabetes mellitus	0.000771	0.215	CrCbGaD
Almotriptan—HTR1B—artery—type 2 diabetes mellitus	0.000643	0.111	CbGeAlD
Almotriptan—HTR1D—artery—type 2 diabetes mellitus	0.000623	0.108	CbGeAlD
Almotriptan—Melatonin—CALM1—type 2 diabetes mellitus	0.000472	0.132	CrCbGaD
Almotriptan—MAOA—nerve—type 2 diabetes mellitus	0.00047	0.0815	CbGeAlD
Almotriptan—FMO3—adipose tissue—type 2 diabetes mellitus	0.000336	0.0582	CbGeAlD
Almotriptan—Rizatriptan—CYP1A2—type 2 diabetes mellitus	0.000317	0.0886	CrCbGaD
Almotriptan—Zolmitriptan—CYP1A2—type 2 diabetes mellitus	0.00029	0.0811	CrCbGaD
Almotriptan—FMO3—liver—type 2 diabetes mellitus	0.000236	0.0408	CbGeAlD
Almotriptan—MAOA—islet of Langerhans—type 2 diabetes mellitus	0.000228	0.0395	CbGeAlD
Almotriptan—HTR1B—cardiovascular system—type 2 diabetes mellitus	0.000223	0.0387	CbGeAlD
Almotriptan—HTR1D—cardiovascular system—type 2 diabetes mellitus	0.000216	0.0375	CbGeAlD
Almotriptan—HTR1D—kidney—type 2 diabetes mellitus	0.000212	0.0367	CbGeAlD
Almotriptan—MAOA—retina—type 2 diabetes mellitus	0.000195	0.0338	CbGeAlD
Almotriptan—MAOA—nephron tubule—type 2 diabetes mellitus	0.000183	0.0318	CbGeAlD
Almotriptan—MAOA—cardiovascular system—type 2 diabetes mellitus	0.000165	0.0286	CbGeAlD
Almotriptan—MAOA—kidney—type 2 diabetes mellitus	0.000161	0.0279	CbGeAlD
Almotriptan—MAOA—pancreas—type 2 diabetes mellitus	0.00016	0.0278	CbGeAlD
Almotriptan—MAOA—cortex of kidney—type 2 diabetes mellitus	0.000157	0.0272	CbGeAlD
Almotriptan—Melatonin—CYP1A2—type 2 diabetes mellitus	0.000149	0.0415	CrCbGaD
Almotriptan—MAOA—adipose tissue—type 2 diabetes mellitus	0.000145	0.0252	CbGeAlD
Almotriptan—CYP2C8—kidney—type 2 diabetes mellitus	0.000144	0.0249	CbGeAlD
Almotriptan—CYP2E1—nephron tubule—type 2 diabetes mellitus	0.000138	0.0239	CbGeAlD
Almotriptan—CYP2E1—cardiovascular system—type 2 diabetes mellitus	0.000124	0.0214	CbGeAlD
Almotriptan—CYP2E1—kidney—type 2 diabetes mellitus	0.000121	0.021	CbGeAlD
Almotriptan—CYP2E1—cortex of kidney—type 2 diabetes mellitus	0.000118	0.0204	CbGeAlD
Almotriptan—Eletriptan—CYP3A4—type 2 diabetes mellitus	0.000113	0.0317	CrCbGaD
Almotriptan—CYP2C19—liver—type 2 diabetes mellitus	0.000104	0.018	CbGeAlD
Almotriptan—MAOA—liver—type 2 diabetes mellitus	0.000102	0.0177	CbGeAlD
Almotriptan—CYP3A4—kidney—type 2 diabetes mellitus	9.73e-05	0.0169	CbGeAlD
Almotriptan—Chest pain—Metformin—type 2 diabetes mellitus	9.59e-05	0.000665	CcSEcCtD
Almotriptan—Malaise—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000665	CcSEcCtD
Almotriptan—CYP2D6—kidney—type 2 diabetes mellitus	9.58e-05	0.0166	CbGeAlD
Almotriptan—Vertigo—Irbesartan—type 2 diabetes mellitus	9.55e-05	0.000662	CcSEcCtD
Almotriptan—Headache—Pioglitazone—type 2 diabetes mellitus	9.55e-05	0.000662	CcSEcCtD
Almotriptan—Syncope—Irbesartan—type 2 diabetes mellitus	9.54e-05	0.000661	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	9.53e-05	0.00066	CcSEcCtD
Almotriptan—Visual impairment—Ramipril—type 2 diabetes mellitus	9.5e-05	0.000658	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	9.49e-05	0.000658	CcSEcCtD
Almotriptan—Discomfort—Metformin—type 2 diabetes mellitus	9.48e-05	0.000657	CcSEcCtD
Almotriptan—Fatigue—Gliclazide—type 2 diabetes mellitus	9.48e-05	0.000657	CcSEcCtD
Almotriptan—Nausea—Glipizide—type 2 diabetes mellitus	9.45e-05	0.000655	CcSEcCtD
Almotriptan—Vomiting—Glimepiride—type 2 diabetes mellitus	9.44e-05	0.000654	CcSEcCtD
Almotriptan—Vision blurred—Losartan—type 2 diabetes mellitus	9.43e-05	0.000654	CcSEcCtD
Almotriptan—Vomiting—Sitagliptin—type 2 diabetes mellitus	9.41e-05	0.000652	CcSEcCtD
Almotriptan—Pain—Gliclazide—type 2 diabetes mellitus	9.4e-05	0.000651	CcSEcCtD
Almotriptan—Tremor—Losartan—type 2 diabetes mellitus	9.38e-05	0.00065	CcSEcCtD
Almotriptan—Rash—Glimepiride—type 2 diabetes mellitus	9.36e-05	0.000649	CcSEcCtD
Almotriptan—Dermatitis—Glimepiride—type 2 diabetes mellitus	9.35e-05	0.000648	CcSEcCtD
Almotriptan—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	9.35e-05	0.000648	CcSEcCtD
Almotriptan—Rash—Sitagliptin—type 2 diabetes mellitus	9.33e-05	0.000647	CcSEcCtD
Almotriptan—Dermatitis—Sitagliptin—type 2 diabetes mellitus	9.32e-05	0.000646	CcSEcCtD
Almotriptan—Headache—Glimepiride—type 2 diabetes mellitus	9.3e-05	0.000644	CcSEcCtD
Almotriptan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	9.28e-05	0.000644	CcSEcCtD
Almotriptan—Headache—Sitagliptin—type 2 diabetes mellitus	9.27e-05	0.000642	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	9.2e-05	0.000638	CcSEcCtD
Almotriptan—Agitation—Losartan—type 2 diabetes mellitus	9.2e-05	0.000637	CcSEcCtD
Almotriptan—Tinnitus—Ramipril—type 2 diabetes mellitus	9.19e-05	0.000637	CcSEcCtD
Almotriptan—Hypertension—Irbesartan—type 2 diabetes mellitus	9.18e-05	0.000636	CcSEcCtD
Almotriptan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	9.16e-05	0.000635	CcSEcCtD
Almotriptan—Angioedema—Losartan—type 2 diabetes mellitus	9.14e-05	0.000634	CcSEcCtD
Almotriptan—Insomnia—Valsartan—type 2 diabetes mellitus	9.13e-05	0.000633	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	9.09e-05	0.00063	CcSEcCtD
Almotriptan—CYP2C8—liver—type 2 diabetes mellitus	9.08e-05	0.0157	CbGeAlD
Almotriptan—Paraesthesia—Valsartan—type 2 diabetes mellitus	9.07e-05	0.000628	CcSEcCtD
Almotriptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	9.06e-05	0.000628	CcSEcCtD
Almotriptan—Chest pain—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000627	CcSEcCtD
Almotriptan—Myalgia—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000627	CcSEcCtD
Almotriptan—Arthralgia—Irbesartan—type 2 diabetes mellitus	9.05e-05	0.000627	CcSEcCtD
Almotriptan—Shock—Metformin—type 2 diabetes mellitus	9.05e-05	0.000627	CcSEcCtD
Almotriptan—Insomnia—Orlistat—type 2 diabetes mellitus	9.03e-05	0.000626	CcSEcCtD
Almotriptan—Malaise—Losartan—type 2 diabetes mellitus	9.02e-05	0.000625	CcSEcCtD
Almotriptan—Anxiety—Irbesartan—type 2 diabetes mellitus	9.02e-05	0.000625	CcSEcCtD
Almotriptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	9.02e-05	0.000625	CcSEcCtD
Almotriptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	9.02e-05	0.000625	CcSEcCtD
Almotriptan—Dyspnoea—Valsartan—type 2 diabetes mellitus	9e-05	0.000624	CcSEcCtD
Almotriptan—Vertigo—Losartan—type 2 diabetes mellitus	8.99e-05	0.000623	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	8.99e-05	0.000623	CcSEcCtD
Almotriptan—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	8.99e-05	0.000623	CcSEcCtD
Almotriptan—Somnolence—Valsartan—type 2 diabetes mellitus	8.98e-05	0.000622	CcSEcCtD
Almotriptan—Syncope—Losartan—type 2 diabetes mellitus	8.97e-05	0.000622	CcSEcCtD
Almotriptan—Paraesthesia—Orlistat—type 2 diabetes mellitus	8.96e-05	0.000621	CcSEcCtD
Almotriptan—Discomfort—Irbesartan—type 2 diabetes mellitus	8.94e-05	0.00062	CcSEcCtD
Almotriptan—Skin disorder—Metformin—type 2 diabetes mellitus	8.93e-05	0.000619	CcSEcCtD
Almotriptan—Immune system disorder—Ramipril—type 2 diabetes mellitus	8.9e-05	0.000617	CcSEcCtD
Almotriptan—Hyperhidrosis—Metformin—type 2 diabetes mellitus	8.89e-05	0.000616	CcSEcCtD
Almotriptan—Dyspepsia—Valsartan—type 2 diabetes mellitus	8.89e-05	0.000616	CcSEcCtD
Almotriptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	8.85e-05	0.000614	CcSEcCtD
Almotriptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	8.85e-05	0.000614	CcSEcCtD
Almotriptan—Palpitations—Losartan—type 2 diabetes mellitus	8.84e-05	0.000613	CcSEcCtD
Almotriptan—Nausea—Glimepiride—type 2 diabetes mellitus	8.82e-05	0.000611	CcSEcCtD
Almotriptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	8.8e-05	0.00061	CcSEcCtD
Almotriptan—Nausea—Sitagliptin—type 2 diabetes mellitus	8.79e-05	0.000609	CcSEcCtD
Almotriptan—Dyspepsia—Orlistat—type 2 diabetes mellitus	8.78e-05	0.000609	CcSEcCtD
Almotriptan—Asthenia—Glyburide—type 2 diabetes mellitus	8.78e-05	0.000609	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	8.72e-05	0.000604	CcSEcCtD
Almotriptan—Fatigue—Valsartan—type 2 diabetes mellitus	8.71e-05	0.000603	CcSEcCtD
Almotriptan—Abdominal pain—Gliclazide—type 2 diabetes mellitus	8.69e-05	0.000602	CcSEcCtD
Almotriptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	8.69e-05	0.000602	CcSEcCtD
Almotriptan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	8.68e-05	0.000601	CcSEcCtD
Almotriptan—Pruritus—Glyburide—type 2 diabetes mellitus	8.66e-05	0.0006	CcSEcCtD
Almotriptan—Mental disorder—Ramipril—type 2 diabetes mellitus	8.64e-05	0.000599	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	8.61e-05	0.000597	CcSEcCtD
Almotriptan—Fatigue—Orlistat—type 2 diabetes mellitus	8.6e-05	0.000596	CcSEcCtD
Almotriptan—Erythema—Ramipril—type 2 diabetes mellitus	8.58e-05	0.000595	CcSEcCtD
Almotriptan—Shock—Irbesartan—type 2 diabetes mellitus	8.54e-05	0.000592	CcSEcCtD
Almotriptan—Pain—Orlistat—type 2 diabetes mellitus	8.53e-05	0.000591	CcSEcCtD
Almotriptan—Chest pain—Losartan—type 2 diabetes mellitus	8.52e-05	0.00059	CcSEcCtD
Almotriptan—Myalgia—Losartan—type 2 diabetes mellitus	8.52e-05	0.00059	CcSEcCtD
Almotriptan—Arthralgia—Losartan—type 2 diabetes mellitus	8.52e-05	0.00059	CcSEcCtD
Almotriptan—Vomiting—Bromocriptine—type 2 diabetes mellitus	8.51e-05	0.00059	CcSEcCtD
Almotriptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	8.51e-05	0.00059	CcSEcCtD
Almotriptan—CYP1A2—liver—type 2 diabetes mellitus	8.5e-05	0.0147	CbGeAlD
Almotriptan—Anxiety—Losartan—type 2 diabetes mellitus	8.49e-05	0.000588	CcSEcCtD
Almotriptan—Tachycardia—Irbesartan—type 2 diabetes mellitus	8.47e-05	0.000587	CcSEcCtD
Almotriptan—Rash—Bromocriptine—type 2 diabetes mellitus	8.44e-05	0.000585	CcSEcCtD
Almotriptan—Dermatitis—Bromocriptine—type 2 diabetes mellitus	8.43e-05	0.000585	CcSEcCtD
Almotriptan—Skin disorder—Irbesartan—type 2 diabetes mellitus	8.43e-05	0.000584	CcSEcCtD
Almotriptan—Tension—Ramipril—type 2 diabetes mellitus	8.42e-05	0.000584	CcSEcCtD
Almotriptan—Discomfort—Losartan—type 2 diabetes mellitus	8.42e-05	0.000583	CcSEcCtD
Almotriptan—Dysgeusia—Ramipril—type 2 diabetes mellitus	8.4e-05	0.000582	CcSEcCtD
Almotriptan—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	8.39e-05	0.000581	CcSEcCtD
Almotriptan—Headache—Bromocriptine—type 2 diabetes mellitus	8.39e-05	0.000581	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	8.38e-05	0.000581	CcSEcCtD
Almotriptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	8.38e-05	0.00058	CcSEcCtD
Almotriptan—Nervousness—Ramipril—type 2 diabetes mellitus	8.33e-05	0.000578	CcSEcCtD
Almotriptan—Dry mouth—Losartan—type 2 diabetes mellitus	8.33e-05	0.000577	CcSEcCtD
Almotriptan—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	8.26e-05	0.000572	CcSEcCtD
Almotriptan—Paraesthesia—Metformin—type 2 diabetes mellitus	8.26e-05	0.000572	CcSEcCtD
Almotriptan—Confusional state—Losartan—type 2 diabetes mellitus	8.24e-05	0.000571	CcSEcCtD
Almotriptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	8.22e-05	0.00057	CcSEcCtD
Almotriptan—Dyspnoea—Metformin—type 2 diabetes mellitus	8.2e-05	0.000568	CcSEcCtD
Almotriptan—Somnolence—Metformin—type 2 diabetes mellitus	8.18e-05	0.000567	CcSEcCtD
Almotriptan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	8.17e-05	0.000566	CcSEcCtD
Almotriptan—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	8.16e-05	0.000566	CcSEcCtD
Almotriptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	8.1e-05	0.000561	CcSEcCtD
Almotriptan—Dyspepsia—Metformin—type 2 diabetes mellitus	8.09e-05	0.000561	CcSEcCtD
Almotriptan—Tremor—Ramipril—type 2 diabetes mellitus	8.04e-05	0.000557	CcSEcCtD
Almotriptan—Shock—Losartan—type 2 diabetes mellitus	8.04e-05	0.000557	CcSEcCtD
Almotriptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	8.01e-05	0.000555	CcSEcCtD
Almotriptan—Abdominal pain—Valsartan—type 2 diabetes mellitus	7.98e-05	0.000553	CcSEcCtD
Almotriptan—Tachycardia—Losartan—type 2 diabetes mellitus	7.97e-05	0.000552	CcSEcCtD
Almotriptan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	7.96e-05	0.000552	CcSEcCtD
Almotriptan—Nausea—Bromocriptine—type 2 diabetes mellitus	7.95e-05	0.000551	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	7.94e-05	0.00055	CcSEcCtD
Almotriptan—Fatigue—Metformin—type 2 diabetes mellitus	7.93e-05	0.000549	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	7.91e-05	0.000548	CcSEcCtD
Almotriptan—Hyperhidrosis—Losartan—type 2 diabetes mellitus	7.9e-05	0.000547	CcSEcCtD
Almotriptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000547	CcSEcCtD
Almotriptan—Abdominal pain—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000547	CcSEcCtD
Almotriptan—Asthenia—Gliclazide—type 2 diabetes mellitus	7.89e-05	0.000547	CcSEcCtD
Almotriptan—Agitation—Ramipril—type 2 diabetes mellitus	7.89e-05	0.000547	CcSEcCtD
Almotriptan—Angioedema—Ramipril—type 2 diabetes mellitus	7.84e-05	0.000543	CcSEcCtD
Almotriptan—Paraesthesia—Irbesartan—type 2 diabetes mellitus	7.79e-05	0.00054	CcSEcCtD
Almotriptan—Vomiting—Glyburide—type 2 diabetes mellitus	7.78e-05	0.000539	CcSEcCtD
Almotriptan—Pruritus—Gliclazide—type 2 diabetes mellitus	7.78e-05	0.000539	CcSEcCtD
Almotriptan—Malaise—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000536	CcSEcCtD
Almotriptan—Dyspnoea—Irbesartan—type 2 diabetes mellitus	7.74e-05	0.000536	CcSEcCtD
Almotriptan—Rash—Glyburide—type 2 diabetes mellitus	7.72e-05	0.000535	CcSEcCtD
Almotriptan—Somnolence—Irbesartan—type 2 diabetes mellitus	7.72e-05	0.000535	CcSEcCtD
Almotriptan—Dermatitis—Glyburide—type 2 diabetes mellitus	7.71e-05	0.000534	CcSEcCtD
Almotriptan—Vertigo—Ramipril—type 2 diabetes mellitus	7.71e-05	0.000534	CcSEcCtD
Almotriptan—Syncope—Ramipril—type 2 diabetes mellitus	7.69e-05	0.000533	CcSEcCtD
Almotriptan—Headache—Glyburide—type 2 diabetes mellitus	7.67e-05	0.000531	CcSEcCtD
Almotriptan—CYP2E1—liver—type 2 diabetes mellitus	7.65e-05	0.0133	CbGeAlD
Almotriptan—Dyspepsia—Irbesartan—type 2 diabetes mellitus	7.64e-05	0.000529	CcSEcCtD
Almotriptan—Palpitations—Ramipril—type 2 diabetes mellitus	7.58e-05	0.000526	CcSEcCtD
Almotriptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	7.58e-05	0.000525	CcSEcCtD
Almotriptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	7.54e-05	0.000523	CcSEcCtD
Almotriptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	7.52e-05	0.000521	CcSEcCtD
Almotriptan—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	7.52e-05	0.000521	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	7.49e-05	0.000519	CcSEcCtD
Almotriptan—Fatigue—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000519	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	7.44e-05	0.000516	CcSEcCtD
Almotriptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	7.44e-05	0.000516	CcSEcCtD
Almotriptan—Convulsion—Ramipril—type 2 diabetes mellitus	7.43e-05	0.000515	CcSEcCtD
Almotriptan—Pain—Irbesartan—type 2 diabetes mellitus	7.42e-05	0.000514	CcSEcCtD
Almotriptan—Insomnia—Losartan—type 2 diabetes mellitus	7.39e-05	0.000512	CcSEcCtD
Almotriptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	7.35e-05	0.00051	CcSEcCtD
Almotriptan—Paraesthesia—Losartan—type 2 diabetes mellitus	7.33e-05	0.000508	CcSEcCtD
Almotriptan—Myalgia—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000506	CcSEcCtD
Almotriptan—Arthralgia—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000506	CcSEcCtD
Almotriptan—Chest pain—Ramipril—type 2 diabetes mellitus	7.31e-05	0.000506	CcSEcCtD
Almotriptan—Dyspnoea—Losartan—type 2 diabetes mellitus	7.28e-05	0.000505	CcSEcCtD
Almotriptan—Anxiety—Ramipril—type 2 diabetes mellitus	7.28e-05	0.000505	CcSEcCtD
Almotriptan—Nausea—Glyburide—type 2 diabetes mellitus	7.27e-05	0.000504	CcSEcCtD
Almotriptan—Abdominal pain—Metformin—type 2 diabetes mellitus	7.27e-05	0.000504	CcSEcCtD
Almotriptan—Dizziness—Gliclazide—type 2 diabetes mellitus	7.27e-05	0.000504	CcSEcCtD
Almotriptan—Somnolence—Losartan—type 2 diabetes mellitus	7.26e-05	0.000503	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	7.25e-05	0.000503	CcSEcCtD
Almotriptan—Asthenia—Valsartan—type 2 diabetes mellitus	7.25e-05	0.000502	CcSEcCtD
Almotriptan—Discomfort—Ramipril—type 2 diabetes mellitus	7.22e-05	0.0005	CcSEcCtD
Almotriptan—Dyspepsia—Losartan—type 2 diabetes mellitus	7.19e-05	0.000498	CcSEcCtD
Almotriptan—Asthenia—Orlistat—type 2 diabetes mellitus	7.16e-05	0.000496	CcSEcCtD
Almotriptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	7.15e-05	0.000496	CcSEcCtD
Almotriptan—Pruritus—Valsartan—type 2 diabetes mellitus	7.14e-05	0.000495	CcSEcCtD
Almotriptan—Dry mouth—Ramipril—type 2 diabetes mellitus	7.14e-05	0.000495	CcSEcCtD
Almotriptan—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	7.1e-05	0.000492	CcSEcCtD
Almotriptan—Confusional state—Ramipril—type 2 diabetes mellitus	7.06e-05	0.000489	CcSEcCtD
Almotriptan—Pruritus—Orlistat—type 2 diabetes mellitus	7.06e-05	0.000489	CcSEcCtD
Almotriptan—Fatigue—Losartan—type 2 diabetes mellitus	7.04e-05	0.000488	CcSEcCtD
Almotriptan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	7e-05	0.000485	CcSEcCtD
Almotriptan—Vomiting—Gliclazide—type 2 diabetes mellitus	6.99e-05	0.000484	CcSEcCtD
Almotriptan—Pain—Losartan—type 2 diabetes mellitus	6.98e-05	0.000484	CcSEcCtD
Almotriptan—Rash—Gliclazide—type 2 diabetes mellitus	6.93e-05	0.00048	CcSEcCtD
Almotriptan—Dermatitis—Gliclazide—type 2 diabetes mellitus	6.92e-05	0.00048	CcSEcCtD
Almotriptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	6.91e-05	0.000479	CcSEcCtD
Almotriptan—Shock—Ramipril—type 2 diabetes mellitus	6.89e-05	0.000478	CcSEcCtD
Almotriptan—Headache—Gliclazide—type 2 diabetes mellitus	6.89e-05	0.000477	CcSEcCtD
Almotriptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	6.87e-05	0.000476	CcSEcCtD
Almotriptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000475	CcSEcCtD
Almotriptan—Abdominal pain—Irbesartan—type 2 diabetes mellitus	6.86e-05	0.000475	CcSEcCtD
Almotriptan—Tachycardia—Ramipril—type 2 diabetes mellitus	6.83e-05	0.000474	CcSEcCtD
Almotriptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	6.83e-05	0.000473	CcSEcCtD
Almotriptan—Skin disorder—Ramipril—type 2 diabetes mellitus	6.8e-05	0.000471	CcSEcCtD
Almotriptan—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	6.77e-05	0.000469	CcSEcCtD
Almotriptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	6.73e-05	0.000466	CcSEcCtD
Almotriptan—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	6.68e-05	0.000463	CcSEcCtD
Almotriptan—Dizziness—Valsartan—type 2 diabetes mellitus	6.68e-05	0.000463	CcSEcCtD
Almotriptan—Dizziness—Orlistat—type 2 diabetes mellitus	6.6e-05	0.000457	CcSEcCtD
Almotriptan—Asthenia—Metformin—type 2 diabetes mellitus	6.6e-05	0.000457	CcSEcCtD
Almotriptan—Nausea—Gliclazide—type 2 diabetes mellitus	6.53e-05	0.000452	CcSEcCtD
Almotriptan—Pruritus—Metformin—type 2 diabetes mellitus	6.51e-05	0.000451	CcSEcCtD
Almotriptan—Abdominal pain—Losartan—type 2 diabetes mellitus	6.46e-05	0.000447	CcSEcCtD
Almotriptan—Body temperature increased—Losartan—type 2 diabetes mellitus	6.46e-05	0.000447	CcSEcCtD
Almotriptan—Vomiting—Valsartan—type 2 diabetes mellitus	6.42e-05	0.000445	CcSEcCtD
Almotriptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000443	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	6.38e-05	0.000442	CcSEcCtD
Almotriptan—Rash—Valsartan—type 2 diabetes mellitus	6.37e-05	0.000441	CcSEcCtD
Almotriptan—Dermatitis—Valsartan—type 2 diabetes mellitus	6.36e-05	0.000441	CcSEcCtD
Almotriptan—Vomiting—Orlistat—type 2 diabetes mellitus	6.34e-05	0.00044	CcSEcCtD
Almotriptan—Insomnia—Ramipril—type 2 diabetes mellitus	6.33e-05	0.000439	CcSEcCtD
Almotriptan—Headache—Valsartan—type 2 diabetes mellitus	6.33e-05	0.000438	CcSEcCtD
Almotriptan—Diarrhoea—Metformin—type 2 diabetes mellitus	6.29e-05	0.000436	CcSEcCtD
Almotriptan—Rash—Orlistat—type 2 diabetes mellitus	6.29e-05	0.000436	CcSEcCtD
Almotriptan—Paraesthesia—Ramipril—type 2 diabetes mellitus	6.29e-05	0.000436	CcSEcCtD
Almotriptan—Dermatitis—Orlistat—type 2 diabetes mellitus	6.29e-05	0.000436	CcSEcCtD
Almotriptan—Headache—Orlistat—type 2 diabetes mellitus	6.25e-05	0.000433	CcSEcCtD
Almotriptan—Dyspnoea—Ramipril—type 2 diabetes mellitus	6.24e-05	0.000433	CcSEcCtD
Almotriptan—Asthenia—Irbesartan—type 2 diabetes mellitus	6.23e-05	0.000432	CcSEcCtD
Almotriptan—Somnolence—Ramipril—type 2 diabetes mellitus	6.23e-05	0.000431	CcSEcCtD
Almotriptan—Dyspepsia—Ramipril—type 2 diabetes mellitus	6.16e-05	0.000427	CcSEcCtD
Almotriptan—CYP3A4—liver—type 2 diabetes mellitus	6.15e-05	0.0107	CbGeAlD
Almotriptan—Pruritus—Irbesartan—type 2 diabetes mellitus	6.14e-05	0.000426	CcSEcCtD
Almotriptan—Dizziness—Metformin—type 2 diabetes mellitus	6.08e-05	0.000421	CcSEcCtD
Almotriptan—CYP2D6—liver—type 2 diabetes mellitus	6.05e-05	0.0105	CbGeAlD
Almotriptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	6.05e-05	0.000419	CcSEcCtD
Almotriptan—Fatigue—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000418	CcSEcCtD
Almotriptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	6.02e-05	0.000417	CcSEcCtD
Almotriptan—Nausea—Valsartan—type 2 diabetes mellitus	6e-05	0.000416	CcSEcCtD
Almotriptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	5.94e-05	0.000412	CcSEcCtD
Almotriptan—Nausea—Orlistat—type 2 diabetes mellitus	5.93e-05	0.000411	CcSEcCtD
Almotriptan—Asthenia—Losartan—type 2 diabetes mellitus	5.86e-05	0.000406	CcSEcCtD
Almotriptan—Vomiting—Metformin—type 2 diabetes mellitus	5.85e-05	0.000405	CcSEcCtD
Almotriptan—Rash—Metformin—type 2 diabetes mellitus	5.8e-05	0.000402	CcSEcCtD
Almotriptan—Dermatitis—Metformin—type 2 diabetes mellitus	5.79e-05	0.000401	CcSEcCtD
Almotriptan—Pruritus—Losartan—type 2 diabetes mellitus	5.78e-05	0.0004	CcSEcCtD
Almotriptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	5.77e-05	0.0004	CcSEcCtD
Almotriptan—Headache—Metformin—type 2 diabetes mellitus	5.76e-05	0.000399	CcSEcCtD
Almotriptan—Dizziness—Irbesartan—type 2 diabetes mellitus	5.74e-05	0.000398	CcSEcCtD
Almotriptan—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	5.73e-05	0.000397	CcSEcCtD
Almotriptan—Diarrhoea—Losartan—type 2 diabetes mellitus	5.59e-05	0.000387	CcSEcCtD
Almotriptan—Abdominal pain—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000384	CcSEcCtD
Almotriptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000384	CcSEcCtD
Almotriptan—Vomiting—Irbesartan—type 2 diabetes mellitus	5.52e-05	0.000382	CcSEcCtD
Almotriptan—Rash—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000379	CcSEcCtD
Almotriptan—Dermatitis—Irbesartan—type 2 diabetes mellitus	5.47e-05	0.000379	CcSEcCtD
Almotriptan—Nausea—Metformin—type 2 diabetes mellitus	5.46e-05	0.000379	CcSEcCtD
Almotriptan—Headache—Irbesartan—type 2 diabetes mellitus	5.44e-05	0.000377	CcSEcCtD
Almotriptan—Dizziness—Losartan—type 2 diabetes mellitus	5.4e-05	0.000374	CcSEcCtD
Almotriptan—Vomiting—Losartan—type 2 diabetes mellitus	5.19e-05	0.00036	CcSEcCtD
Almotriptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000358	CcSEcCtD
Almotriptan—Nausea—Irbesartan—type 2 diabetes mellitus	5.15e-05	0.000357	CcSEcCtD
Almotriptan—Rash—Losartan—type 2 diabetes mellitus	5.15e-05	0.000357	CcSEcCtD
Almotriptan—Dermatitis—Losartan—type 2 diabetes mellitus	5.14e-05	0.000357	CcSEcCtD
Almotriptan—Headache—Losartan—type 2 diabetes mellitus	5.12e-05	0.000355	CcSEcCtD
Almotriptan—Asthenia—Ramipril—type 2 diabetes mellitus	5.02e-05	0.000348	CcSEcCtD
Almotriptan—Pruritus—Ramipril—type 2 diabetes mellitus	4.95e-05	0.000343	CcSEcCtD
Almotriptan—Nausea—Losartan—type 2 diabetes mellitus	4.85e-05	0.000336	CcSEcCtD
Almotriptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	4.79e-05	0.000332	CcSEcCtD
Almotriptan—Dizziness—Ramipril—type 2 diabetes mellitus	4.63e-05	0.000321	CcSEcCtD
Almotriptan—Vomiting—Ramipril—type 2 diabetes mellitus	4.45e-05	0.000309	CcSEcCtD
Almotriptan—Rash—Ramipril—type 2 diabetes mellitus	4.42e-05	0.000306	CcSEcCtD
Almotriptan—Dermatitis—Ramipril—type 2 diabetes mellitus	4.41e-05	0.000306	CcSEcCtD
Almotriptan—Headache—Ramipril—type 2 diabetes mellitus	4.39e-05	0.000304	CcSEcCtD
Almotriptan—Nausea—Ramipril—type 2 diabetes mellitus	4.16e-05	0.000288	CcSEcCtD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	4.45e-06	6.69e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.44e-06	6.69e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.42e-06	6.66e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.42e-06	6.66e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.42e-06	6.66e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.4e-06	6.62e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.38e-06	6.59e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.35e-06	6.55e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.35e-06	6.55e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.34e-06	6.54e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3R1—type 2 diabetes mellitus	4.34e-06	6.53e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—NOS3—type 2 diabetes mellitus	4.34e-06	6.53e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.33e-06	6.52e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.32e-06	6.5e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.3e-06	6.48e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.29e-06	6.45e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.29e-06	6.45e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	4.24e-06	6.39e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.24e-06	6.38e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.24e-06	6.38e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.22e-06	6.35e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.21e-06	6.34e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.2e-06	6.33e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	4.2e-06	6.33e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.18e-06	6.29e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	4.18e-06	6.29e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	4.18e-06	6.29e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	4.18e-06	6.29e-05	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—AKT1—type 2 diabetes mellitus	4.18e-06	6.29e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	4.17e-06	6.28e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	4.17e-06	6.28e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	4.15e-06	6.25e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	4.15e-06	6.25e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	4.14e-06	6.23e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.14e-06	6.23e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.14e-06	6.23e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	4.08e-06	6.14e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	4.06e-06	6.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	4.06e-06	6.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	4.06e-06	6.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	4.06e-06	6.11e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOS3—type 2 diabetes mellitus	4.05e-06	6.1e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	4.05e-06	6.1e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	4.05e-06	6.09e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	4.03e-06	6.07e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	4.03e-06	6.07e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.03e-06	6.06e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GNB3—type 2 diabetes mellitus	4.03e-06	6.06e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—HMOX1—type 2 diabetes mellitus	4.01e-06	6.03e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	4e-06	6.02e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	4e-06	6.02e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.98e-06	5.99e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PTGS2—type 2 diabetes mellitus	3.97e-06	5.98e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CAT—type 2 diabetes mellitus	3.95e-06	5.95e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.9e-06	5.87e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RELA—type 2 diabetes mellitus	3.89e-06	5.86e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.89e-06	5.86e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOB—type 2 diabetes mellitus	3.84e-06	5.78e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.84e-06	5.77e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.84e-06	5.77e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.82e-06	5.75e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.81e-06	5.74e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.76e-06	5.66e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.75e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.75e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.75e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.75e-06	5.64e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GSTM1—type 2 diabetes mellitus	3.73e-06	5.62e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.68e-06	5.54e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—LPL—type 2 diabetes mellitus	3.67e-06	5.52e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.65e-06	5.49e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.63e-06	5.46e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.62e-06	5.45e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.59e-06	5.41e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.59e-06	5.41e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.59e-06	5.41e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ADCY5—type 2 diabetes mellitus	3.59e-06	5.4e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.58e-06	5.39e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—GPX1—type 2 diabetes mellitus	3.58e-06	5.38e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.57e-06	5.37e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.57e-06	5.37e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.55e-06	5.35e-05	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.54e-06	5.34e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.53e-06	5.31e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.51e-06	5.29e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.51e-06	5.29e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.49e-06	5.25e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CD36—type 2 diabetes mellitus	3.48e-06	5.24e-05	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.47e-06	5.22e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPP2CA—type 2 diabetes mellitus	3.44e-06	5.18e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.44e-06	5.18e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.43e-06	5.16e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.43e-06	5.16e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.42e-06	5.14e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.39e-06	5.1e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.38e-06	5.08e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.33e-06	5.02e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.32e-06	5e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.31e-06	4.98e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.31e-06	4.98e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.31e-06	4.98e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.31e-06	4.98e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.3e-06	4.97e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—MTHFR—type 2 diabetes mellitus	3.3e-06	4.97e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.29e-06	4.95e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.29e-06	4.95e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.28e-06	4.94e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.27e-06	4.93e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MMP9—type 2 diabetes mellitus	3.25e-06	4.89e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.25e-06	4.89e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.25e-06	4.89e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.25e-06	4.89e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	3.24e-06	4.88e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARA—type 2 diabetes mellitus	3.24e-06	4.87e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	3.22e-06	4.85e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	3.22e-06	4.85e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	3.22e-06	4.85e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.22e-06	4.85e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	3.22e-06	4.84e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	3.2e-06	4.82e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.2e-06	4.82e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.19e-06	4.81e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	3.15e-06	4.74e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.15e-06	4.74e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.15e-06	4.74e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AGT—type 2 diabetes mellitus	3.14e-06	4.72e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.11e-06	4.68e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	3.11e-06	4.68e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	3.1e-06	4.66e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CALM1—type 2 diabetes mellitus	3.08e-06	4.64e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOE—type 2 diabetes mellitus	3.07e-06	4.63e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	3.07e-06	4.62e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	3.07e-06	4.62e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SRC—type 2 diabetes mellitus	3.06e-06	4.61e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—APOA1—type 2 diabetes mellitus	3.04e-06	4.57e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	3.04e-06	4.57e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	3.01e-06	4.53e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SRC—type 2 diabetes mellitus	3e-06	4.51e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.98e-06	4.49e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.95e-06	4.43e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.95e-06	4.43e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.94e-06	4.42e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.92e-06	4.39e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.89e-06	4.35e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.89e-06	4.35e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.89e-06	4.35e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.89e-06	4.35e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.86e-06	4.3e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.84e-06	4.27e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.82e-06	4.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.81e-06	4.23e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.8e-06	4.22e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.8e-06	4.22e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.8e-06	4.21e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.79e-06	4.2e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.78e-06	4.19e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.75e-06	4.14e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.75e-06	4.14e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.75e-06	4.14e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.74e-06	4.13e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.74e-06	4.12e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.71e-06	4.08e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.71e-06	4.08e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.68e-06	4.04e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.68e-06	4.03e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PPARG—type 2 diabetes mellitus	2.68e-06	4.03e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.67e-06	4.02e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.66e-06	4.01e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.66e-06	4.01e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.66e-06	4e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.65e-06	3.98e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.63e-06	3.95e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—INS—type 2 diabetes mellitus	2.63e-06	3.95e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.62e-06	3.94e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.62e-06	3.94e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.6e-06	3.91e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.57e-06	3.88e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.55e-06	3.84e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.53e-06	3.81e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.52e-06	3.8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.51e-06	3.77e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.51e-06	3.77e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.5e-06	3.76e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.49e-06	3.75e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.49e-06	3.74e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.44e-06	3.67e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.42e-06	3.65e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ALB—type 2 diabetes mellitus	2.41e-06	3.62e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.39e-06	3.6e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.39e-06	3.6e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.34e-06	3.53e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—NOS3—type 2 diabetes mellitus	2.3e-06	3.47e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3R1—type 2 diabetes mellitus	2.3e-06	3.47e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.3e-06	3.46e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.25e-06	3.39e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.2e-06	3.31e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.18e-06	3.28e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.16e-06	3.25e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.16e-06	3.25e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.16e-06	3.24e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.15e-06	3.24e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.15e-06	3.23e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.14e-06	3.23e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.14e-06	3.22e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.12e-06	3.2e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.11e-06	3.18e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PTGS2—type 2 diabetes mellitus	2.11e-06	3.17e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL6—type 2 diabetes mellitus	2.06e-06	3.1e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.06e-06	3.1e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	2.05e-06	3.09e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	2.05e-06	3.09e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL6—type 2 diabetes mellitus	2.02e-06	3.04e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2e-06	3.02e-05	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—AKT1—type 2 diabetes mellitus	2e-06	3e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.98e-06	2.97e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.97e-06	2.96e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.93e-06	2.9e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.92e-06	2.89e-05	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.9e-06	2.86e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.89e-06	2.84e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.89e-06	2.84e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.88e-06	2.83e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.87e-06	2.81e-05	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.86e-06	2.8e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.86e-06	2.8e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.85e-06	2.78e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.83e-06	2.75e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.77e-06	2.67e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.74e-06	2.62e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.73e-06	2.6e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.68e-06	2.53e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.67e-06	2.52e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.66e-06	2.49e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.65e-06	2.48e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.63e-06	2.45e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.6e-06	2.41e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.6e-06	2.41e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.46e-06	2.2e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.44e-06	2.16e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.41e-06	2.12e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.29e-06	1.94e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.24e-06	1.86e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.24e-06	1.86e-05	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.22e-06	1.84e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.13e-06	1.7e-05	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—AKT1—type 2 diabetes mellitus	1.06e-06	1.59e-05	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.45e-07	1.42e-05	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.69e-07	1.31e-05	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.36e-07	1.11e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.68e-07	8.55e-06	CbGpPWpGaD
